BiomeMega specializes in the research, development, and production of proprietary probiotic formulations that deliver Omega 3, 6, 7, and 9 fatty acids. Utilizing precision fermentation, the company creates scalable, non-GMO ingredients for the nutraceutical, food, and pharmaceutical sectors. Their platform also explores functional peptides and probiotic membranes for advanced health and cosmetic applications.
Funding
Funding not disclosed
Founders
Product
Problem
Current methods of obtaining Omega 3, 6, 7, and 9 oils often rely on unsustainable sources and may have limited bioavailability, hindering their effectiveness in preventing chronic diseases and improving overall health. Traditional extraction methods can also be environmentally damaging and lack the scalability needed to meet growing demand.
Solution
BiomeMega utilizes precision fermentation to produce probiotic-derived Omega 3, 6, 7, and 9 oils, offering a sustainable and bioavailable alternative to traditional sources. Their proprietary probiotic formulations continuously deliver essential fatty acids, enhancing their potential to prevent chronic diseases and improve overall health. By leveraging precision fermentation, BiomeMega achieves scalability and creates customized fatty acid profiles for various applications in the nutraceutical, food, and pharmaceutical industries. The company's research also explores the use of probiotic membranes as medicines and functional peptides for ex vivo modification and delivery.
Target Audience
BiomeMega's primary customers are companies in the nutraceutical, food, and pharmaceutical industries seeking sustainable, bioavailable, and customizable sources of Omega 3, 6, 7, and 9 oils.
Features
- Proprietary probiotic formulations for continuous delivery of Omega 3, 6, 7, and 9 oils
- Precision fermentation process for scalable and sustainable production
- Customizable fatty acid profiles to meet specific industry needs
- Non-GMO animal trials demonstrating increased lean muscle growth, improved gut health, and prevention of obesity and diabetes
- Development of functional peptides for ex vivo modification and delivery through omega membrane fragments
- Research into the use of probiotic membranes as medicines